NASDAQ : XGN

Exagen Inc. — Financial statements

Healthcare · Diagnostics & Research · United States

Last price 8.59 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 208.10M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Exagen Inc. (XGN) reported revenue of 71.12M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue71.12M66.58M55.64M52.55M45.56M48.30M
Cost of Revenue29.42M27.78M22.53M23.09M24.21M20.59M
Gross Profit41.70M38.80M33.11M29.46M21.35M27.71M
Selling, General & Admin48.45M46.62M41.37M47.43M52.02M44.54M
Research & Development6.47M6.25M5.38M4.87M9.48M7.24M
Operating Expenses54.91M52.87M46.75M52.29M61.50M51.78M
Operating Income-13.21M-14.07M-13.64M-22.84M-40.15M-24.07M
Interest Expense-5.12M-4.32M-2.23M-2.33M-2.45M-2.62M
Interest & Investment Income289.00K289.00K767.00K1.52M830.00K16.00K
Other Non Operating Income (Expenses)-222.00K
EBT Excluding Unusual Items-18.26M-18.10M-15.10M-23.66M-41.77M-26.68M
Impairment of Goodwill-5.51M
Asset Writedown-397.00K
Other Unusual Items-612.00K-1.80M
Pretax Income-18.87M-19.90M-15.10M-23.66M-47.67M-26.68M
Income Tax Expense50.00K51.00K12.00K33.00K-282.00K175.00K
Net Income-18.92M-19.95M-15.12M-23.69M-47.39M-26.85M
Net Income to Common-18.92M-19.95M-15.12M-23.69M-47.39M-26.85M
Shares Outstanding (Basic)23.65M21.56M18.20M17.68M17.08M15.97M
Shares Outstanding (Diluted)23.65M21.56M18.20M17.68M17.08M15.97M
EPS (Basic)-0.80-0.93-0.83-1.34-2.77-1.68
EPS (Diluted)-0.80-0.93-0.83-1.34-2.77-1.68
Free Cash Flow-7.59M-14.27M-13.79M-15.29M-36.46M-22.64M
Free Cash Flow Per Share-0.32-0.66-0.76-0.86-2.13-1.42
Gross Margin58.64%58.28%59.51%56.05%46.86%57.37%
Operating Margin-18.57%-21.13%-24.51%-43.46%-88.11%-49.83%
Profit Margin-26.61%-29.97%-27.16%-45.08%-104.00%-55.59%
Free Cash Flow Margin-10.67%-21.43%-24.79%-29.10%-80.03%-46.87%
EBITDA-10.77M-11.95M-11.91M-20.67M-38.59M-23.12M
EBITDA Margin-15.15%-17.95%-21.41%-39.33%-84.70%-47.87%
D&A For EBITDA2.44M2.12M1.72M2.17M1.56M948.00K
EBIT-13.21M-14.07M-13.64M-22.84M-40.15M-24.07M
EBIT Margin-18.57%-21.13%-24.51%-43.46%-88.11%-49.83%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents24.59M32.22M22.04M36.49M62.39M99.44M
Cash & Short-Term Investments24.59M32.22M22.04M36.49M62.39M99.44M
Receivables12.41M10.86M7.83M6.55M6.08M9.65M
Inventory4.16M3.30M5.72M2.87M1.79M1.09M
Prepaid Expenses1.20M1.34M859.00K1.93M2.35M2.55M
Other Current Assets505.00K1.18M
Total Current Assets42.86M48.89M36.45M47.84M72.61M112.73M
Property, Plant & Equipment8.52M8.37M7.68M8.49M13.08M4.77M
Goodwill5.51M
Other Long-Term Assets560.00K756.00K550.00K616.00K528.00K433.00K
Total Assets51.94M58.02M44.69M56.94M86.22M123.44M
Accounts Payable4.44M4.15M4.14M3.13M3.05M2.49M
Accrued Expenses4.94M6.33M6.92M7.04M4.20M6.24M
Current Portion of Long-Term Debt517.00K643.00K423.00K264.00K190.00K
Current Portion of Leases2.07M2.36M1.30M1.47M1.74M587.00K
Current Unearned Revenue1.49M675.00K733.00K
Other Current Liabilities445.00K
Total Current Liabilities13.46M14.16M13.51M11.90M9.62M9.32M
Long-Term Debt22.32M22.26M19.82M19.23M28.78M27.48M
Long-Term Leases2.75M2.40M1.82M3.12M5.34M
Long-Term Deferred Tax Liabilities306.00K
Other Long-Term Liabilities1.19M1.75M19.00K1.41M
Total Liabilities39.72M40.57M35.15M34.25M43.76M38.51M
Common Stock24.00K23.00K18.00K17.00K17.00K16.00K
Additional Paid-In Capital333.64M331.71M303.85M301.89M297.97M293.06M
Retained Earnings-321.44M-314.28M-294.33M-279.22M-255.53M-208.14M
Total Common Equity12.22M17.45M9.54M22.69M42.46M84.94M
Shareholders' Equity12.22M17.45M9.54M22.69M42.46M84.94M
Total Liabilities & Equity51.94M58.02M44.69M56.94M86.22M123.44M
Total Debt27.66M27.67M23.36M24.08M36.05M28.07M
Net Cash (Debt)-3.07M4.55M-1.33M12.41M26.34M71.38M
Net Cash Per Share-0.130.21-0.070.701.544.47
Filing Date Shares Outstanding24.23M24.05M17.90M17.24M16.83M16.23M
Total Common Shares Outstanding24.19M22.91M17.64M17.05M16.55M16.16M
Working Capital29.40M34.73M22.95M35.94M62.99M103.42M
Book Value Per Share0.500.760.541.332.575.25
Tangible Book Value12.22M17.45M9.54M22.69M42.46M79.43M
Tangible Book Value Per Share0.500.760.541.332.574.91
Machinery8.10M6.77M5.21M5.09M3.92M3.15M
Construction In Progress384.00K294.00K1.54M59.00K1.38M1.85M
Leasehold Improvements3.38M3.31M3.26M3.32M5.22M1.15M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-18.92M-19.95M-15.12M-23.69M-47.39M-26.85M
Depreciation & Amortization2.44M2.12M1.72M2.17M1.56M948.00K
Other Amortization530.00K378.00K154.00K156.00K161.00K279.00K
Loss (Gain) From Sale of Assets189.00K
Asset Writedown & Restructuring Costs5.90M
Stock-Based Compensation2.93M2.16M1.76M3.62M4.70M4.73M
Other Operating Activities2.92M3.65M1.27M2.77M1.25M688.00K
Change in Accounts Receivable2.32M-3.02M-1.28M-474.00K3.58M-744.00K
Change in Accounts Payable1.82M42.00K308.00K67.00K901.00K-655.00K
Change in Unearned Revenue476.00K-58.00K733.00K
Change in Other Net Operating Assets-553.00K1.05M-2.83M732.00K-2.81M1.34M
Operating Cash Flow-6.50M-13.62M-13.28M-14.46M-32.14M-20.27M
Capital Expenditures-1.09M-641.00K-515.00K-828.00K-4.32M-2.37M
Sale of Property, Plant & Equipment9.00K15.00K24.00K
Other Investing Activities-50.00K
Investing Cash Flow-1.08M-626.00K-515.00K-804.00K-4.32M-2.42M
Long-Term Debt Issued23.67M
Total Debt Issued23.67M
Long-Term Debt Repaid-20.79M-861.00K-10.94M-696.00K-525.00K
Total Debt Repaid-1.41M-20.79M-861.00K-10.94M-696.00K-525.00K
Net Debt Issued (Repaid)-1.41M2.88M-861.00K-10.94M-696.00K-525.00K
Issuance of Common Stock3.74M22.42M198.00K306.00K446.00K69.66M
Repurchase of Common Stock-239.00K
Other Financing Activities-199.00K-869.00K-4.45M
Financing Cash Flow2.13M24.43M-663.00K-10.63M-489.00K64.68M
Net Cash Flow-5.45M10.18M-14.46M-25.90M-36.95M41.99M
Free Cash Flow-7.59M-14.27M-13.79M-15.29M-36.46M-22.64M
Free Cash Flow Margin-10.67%-21.43%-24.79%-29.10%-80.03%-46.87%
Free Cash Flow Per Share-0.32-0.66-0.76-0.86-2.13-1.42
Levered Free Cash Flow-1.56M-10.36M-8.25M-9.27M-22.48M-13.05M
Unlevered Free Cash Flow1.11M-8.04M-7.01M-7.97M-21.12M-11.69M
Cash Interest Paid3.48M2.99M1.72M1.74M1.73M1.81M
Cash Income Tax Paid35.00K35.00K32.00K
Change in Working Capital4.06M-1.98M-3.08M325.00K1.67M-61.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization208.10M137.79M72.31M33.92M39.17M187.99M
Enterprise Value211.16M130.31M74.02M30.71M5.95M109.10M
Last Close Price8.596.084.101.992.4011.63
PS Ratio2.932.071.300.650.863.89
PB Ratio17.017.907.581.500.922.21
P/TBV Ratio17.037.907.581.500.922.37
EV/Sales Ratio2.971.961.330.580.132.26
Debt / Equity Ratio2.261.592.451.060.850.33
Net Debt / Equity Ratio0.25-0.260.14-0.55-0.62-0.84
Net Debt / EBITDA Ratio-0.280.38-0.110.600.683.09
Net Debt / FCF Ratio-0.400.32-0.100.810.723.15
Asset Turnover1.281.301.090.730.430.48
Inventory Turnover7.456.165.249.9016.7817.95
Quick Ratio2.753.042.213.627.1211.71
Current Ratio3.193.452.704.027.5512.10
Return on Equity (ROE)-113.82%-147.84%-93.78%-72.72%-74.39%-42.36%
Return on Assets (ROA)-14.92%-17.12%-16.77%-19.94%-23.94%-14.91%
Return on Capital Employed (ROCE)-34.30%-32.10%-43.70%-50.70%-52.40%-21.10%
Earnings Yield-9.31%-14.48%-20.90%-69.84%-120.99%-14.28%
FCF Yield-3.65%-10.35%-19.07%-45.07%-93.09%-12.04%
Buyback Yield / Dilution-23.90%-18.43%-2.96%-3.50%-6.95%-26.43%